Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective

被引：2
|
作者：
Luster, Markus [1 ]
Schlumberger, Martin [2 ]
Pacini, Furio [3 ]
机构：
[1] Univ Ulm, Dept Nucl Med, D-89081 Ulm, Germany
[2] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, F-94805 Villejuif, France
[3] Univ Siena, Sect Endocrinol & Metab, Dept Internal Med, I-53100 Siena, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷 / 02期
关键词：
HORMONE WITHDRAWAL; RADIOIODINE THERAPY; MANAGEMENT; CARCINOMA; DOSIMETRY; ABLATION;
D O I：
10.1007/s00259-008-1013-9
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [11] Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH
    Sugino, Kimintori
    Ito, Koichi
    Takami, Hiroshi
    ENDOCRINE JOURNAL, 2006, 53 (06) : 723 - 728
  • [12] Is recombinant human TSH as effective as thyroid hormone withdrawal in the detection and treatment of metastatic differentiated thyroid cancer?
    Iervasi, Giorgio
    Bottoni, Antonio
    Filidei, Elena
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2012, 7 (06) : 633 - 635
  • [13] The role of nuclear medicine in differentiated thyroid cancer
    Kohlfuerst, Susanne
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2012, 162 (19-20) : 407 - 415
  • [14] Nuclear medicine in the assessment of differentiated thyroid cancer
    Rutherford, G. -C.
    Franc, B.
    O'Connor, A.
    CLINICAL RADIOLOGY, 2008, 63 (04) : 453 - 463
  • [15] The use of recombinant human TSH in the evaluation of patients with differentiated thyroid carcinoma
    Rondogianni, PH
    Vlassopoulou, V
    Tzavara, I
    Giannakopoulos, PH
    Giannopoulou, CH
    Nikolou, H
    Thalassinos, N
    Houssianakou, I
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1042 - 1042
  • [16] Predictive Value of Recombinant Human TSH Stimulation and Neck Ultrasonography in Differentiated Thyroid Cancer Patients
    Crocetti, Umberto
    Durante, Cosimo
    Attard, Marco
    Maniglia, Adele
    Tumino, Salvatore
    Bruno, Rocco
    Bonfitto, Nazario
    Dicembrino, Franca
    Varraso, Antonio
    Meringolo, Domenico
    Filetti, Sebastiano
    Trischitta, Vincenzo
    Torlontano, Massimo
    THYROID, 2008, 18 (10) : 1049 - 1053
  • [17] Expanding indications for recombinant human TSH in thyroid cancer
    Haugen, Bryan R.
    Cooper, David S.
    Emerson, Charles H.
    Luster, Markus
    Maciel, Rui M. B.
    Biscolla, Rosa P. M.
    Mazzaferri, Ernest L.
    Medeiros-Neto, Geraldo
    Reiners, Christoph
    Robbins, Richard J.
    Robinson, Bruce G.
    Schlumberger, Martin
    Yamashita, Shunichi
    Pacini, Furio
    THYROID, 2008, 18 (07) : 687 - 694
  • [18] Influence of clinical factors on serum peak thyrotropin (TSH) after recombinant human TSH administration in patients with differentiated thyroid cancer
    Son, Seung Hyun
    Hong, Chae Moon
    Jung, Ji-Hoon
    Kim, Choon-Young
    Kim, Do-Hoon
    Jeong, Shin Young
    Lee, Sang-Woo
    Ahn, Byeong-Cheol
    Lee, Jaetae
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [19] Influence of clinical factors on serum peak thyrotropin (TSH) after recombinant human TSH administration in patients with differentiated thyroid cancer
    Son, Seung Hyun
    Hong, Chae Moon
    Jung, Ji-hoon
    Kim, Choon-Young
    Kim, Do-Hoon
    Jeong, Shin Young
    Lee, Sang-Woo
    Ahn, Byeong-Cheol
    Lee, Jaetae
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [20] Using recombinant human TSH in the management of well-differentiated thyroid cancer: Current strategies and future directions
    Mazzaferri, EL
    Kloos, RT
    THYROID, 2000, 10 (09) : 767 - 778
12345